Cite
HARVARD Citation
Morimoto, C. et al. (2021). High serum free IL-18 is associated with decreased omalizumab efficacy: findings from a 2-year omalizumab treatment study. Journal of asthma. pp. 1133-1142. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Morimoto, C. et al. (2021). High serum free IL-18 is associated with decreased omalizumab efficacy: findings from a 2-year omalizumab treatment study. Journal of asthma. pp. 1133-1142. [Online].